Symptoms of overdose include abdominal irritation, central nervous system depression, coma, extremely slow heartbeat, heart failure, lethargy, low blood pressure, and wheezing.
A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Duloxetine | The risk or severity of orthostatic hypotension and syncope can be increased when Oxprenolol is combined with Duloxetine. |
| Levodopa | The risk or severity of hypotension and orthostatic hypotension can be increased when Oxprenolol is combined with Levodopa. |
| Risperidone | Oxprenolol may increase the hypotensive activities of Risperidone. |
| Ceritinib | Oxprenolol may increase the bradycardic activities of Ceritinib. |
| Ivabradine | Oxprenolol may increase the bradycardic activities of Ivabradine. |
| Ruxolitinib | Ruxolitinib may increase the bradycardic activities of Oxprenolol. |
| Alfuzosin | Alfuzosin may increase the hypotensive activities of Oxprenolol. |
| Amifostine | Oxprenolol may increase the hypotensive activities of Amifostine. |
| Diazoxide | Diazoxide may increase the hypotensive activities of Oxprenolol. |
| Methylphenidate | Methylphenidate may decrease the antihypertensive activities of Oxprenolol. |
| Dexmethylphenidate | Dexmethylphenidate may decrease the antihypertensive activities of Oxprenolol. |
| Obinutuzumab | Oxprenolol may increase the hypotensive activities of Obinutuzumab. |
| Pentoxifylline | Pentoxifylline may increase the hypotensive activities of Oxprenolol. |
| Rituximab | Oxprenolol may increase the hypotensive activities of Rituximab. |
| Desmopressin | Desmopressin may decrease the antihypertensive activities of Oxprenolol. |
| Doxapram | Doxapram may decrease the antihypertensive activities of Oxprenolol. |
| Phenmetrazine | Phenmetrazine may decrease the antihypertensive activities of Oxprenolol. |
| Dutasteride | Dutasteride may decrease the antihypertensive activities of Oxprenolol. |
| Finasteride | Finasteride may decrease the antihypertensive activities of Oxprenolol. |
| Epicaptopril | Epicaptopril may decrease the antihypertensive activities of Oxprenolol. |
| 1-benzylimidazole | 1-benzylimidazole may decrease the antihypertensive activities of Oxprenolol. |
| Tyramine | Tyramine may decrease the antihypertensive activities of Oxprenolol. |
| Moxisylyte | Moxisylyte may decrease the antihypertensive activities of Oxprenolol. |
| Atipamezole | Atipamezole may decrease the antihypertensive activities of Oxprenolol. |
| Siponimod | Siponimod may decrease the antihypertensive activities of Oxprenolol. |
| Idazoxan | Idazoxan may decrease the antihypertensive activities of Oxprenolol. |
| Tramazoline | Tramazoline may decrease the antihypertensive activities of Oxprenolol. |
| Fenozolone | Fenozolone may decrease the antihypertensive activities of Oxprenolol. |
| Xenon | Xenon may decrease the antihypertensive activities of Oxprenolol. |
| Buflomedil | Buflomedil may decrease the antihypertensive activities of Oxprenolol. |
| Mefenorex | Mefenorex may decrease the antihypertensive activities of Oxprenolol. |
| Quinoline Yellow WS | Quinoline Yellow WS may decrease the antihypertensive activities of Oxprenolol. |
| Selpercatinib | Selpercatinib may decrease the antihypertensive activities of Oxprenolol. |
| Naxitamab | Naxitamab may decrease the antihypertensive activities of Oxprenolol. |
| Buprenorphine | Oxprenolol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Oxprenolol. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Oxprenolol. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxprenolol. |
| Hydrocodone | Oxprenolol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Magnesium sulfate | The therapeutic efficacy of Oxprenolol can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Oxprenolol may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Oxprenolol may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Oxprenolol. |
| Mirtazapine | Oxprenolol may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Oxprenolol. |
| Orphenadrine | Oxprenolol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Oxprenolol may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Oxprenolol. |
| Pramipexole | Oxprenolol may increase the sedative activities of Pramipexole. |
| Ropinirole | Oxprenolol may increase the sedative activities of Ropinirole. |
| Rotigotine | Oxprenolol may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Oxprenolol. |
| Sodium oxybate | Oxprenolol may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Oxprenolol may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Oxprenolol. |
| Thalidomide | Oxprenolol may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Oxprenolol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Yohimbine | The therapeutic efficacy of Oxprenolol can be increased when used in combination with Yohimbine. |
| Amiodarone | The therapeutic efficacy of Oxprenolol can be increased when used in combination with Amiodarone. |
| Bupivacaine | The serum concentration of Bupivacaine can be increased when it is combined with Oxprenolol. |
| Dipyridamole | Dipyridamole may increase the bradycardic activities of Oxprenolol. |
| Disopyramide | Disopyramide may increase the bradycardic activities of Oxprenolol. |
| Dronedarone | Dronedarone may increase the bradycardic activities of Oxprenolol. |
| Fingolimod | Oxprenolol may increase the bradycardic activities of Fingolimod. |
| Floctafenine | The risk or severity of adverse effects can be increased when Oxprenolol is combined with Floctafenine. |
| Mepivacaine | The serum concentration of Mepivacaine can be increased when it is combined with Oxprenolol. |
| Methacholine | Oxprenolol may increase the bronchoconstrictory activities of Methacholine. |
| Midodrine | The therapeutic efficacy of Midodrine can be decreased when used in combination with Oxprenolol. |
| Nifedipine | The risk or severity of congestive heart failure and hypotension can be increased when Nifedipine is combined with Oxprenolol. |
| Propafenone | The risk or severity of adverse effects can be increased when Propafenone is combined with Oxprenolol. |
| Regorafenib | Regorafenib may increase the bradycardic activities of Oxprenolol. |
| Reserpine | Reserpine may increase the hypotensive activities of Oxprenolol. |
| Deserpidine | Deserpidine may increase the hypotensive activities of Oxprenolol. |
| Guanethidine | Guanethidine may increase the hypotensive activities of Oxprenolol. |
| Rivastigmine | Oxprenolol may increase the bradycardic activities of Rivastigmine. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Oxprenolol. |
| Atomoxetine | The metabolism of Atomoxetine can be decreased when combined with Oxprenolol. |
| Mirabegron | The serum concentration of Oxprenolol can be increased when it is combined with Mirabegron. |
| Nicorandil | Nicorandil may increase the hypotensive activities of Oxprenolol. |
| Molsidomine | Molsidomine may increase the hypotensive activities of Oxprenolol. |
| Insulin argine | Oxprenolol may increase the hypoglycemic activities of Insulin argine. |
| Dorzolamide | Dorzolamide may increase the hypotensive activities of Oxprenolol. |
| Bimatoprost | Bimatoprost may increase the hypotensive activities of Oxprenolol. |
| Unoprostone | Oxprenolol may increase the hypotensive activities of Unoprostone. |
| Torasemide | Torasemide may increase the hypotensive activities of Oxprenolol. |
| Chlorthalidone | Chlorthalidone may increase the hypotensive activities of Oxprenolol. |
| Nitroprusside | Nitroprusside may increase the hypotensive activities of Oxprenolol. |
| Minoxidil | Minoxidil may increase the hypotensive activities of Oxprenolol. |
| Metolazone | Metolazone may increase the hypotensive activities of Oxprenolol. |
| Mecamylamine | Mecamylamine may increase the hypotensive activities of Oxprenolol. |
| Furosemide | Furosemide may increase the hypotensive activities of Oxprenolol. |
| Nitroglycerin | Nitroglycerin may increase the hypotensive activities of Oxprenolol. |
| Fenoldopam | Fenoldopam may increase the hypotensive activities of Oxprenolol. |
| Hydralazine | Hydralazine may increase the hypotensive activities of Oxprenolol. |
| Remikiren | Remikiren may increase the hypotensive activities of Oxprenolol. |
| Guanadrel | Guanadrel may increase the hypotensive activities of Oxprenolol. |
| Bosentan | Bosentan may increase the hypotensive activities of Oxprenolol. |
| Candoxatril | Candoxatril may increase the hypotensive activities of Oxprenolol. |
| Cryptenamine | Cryptenamine may increase the hypotensive activities of Oxprenolol. |
| Pentolinium | Pentolinium may increase the hypotensive activities of Oxprenolol. |